Release Date: 17/06/09 08:25 Summary: Ceasing to be a substantial holder Price Sensitive: No Download Document 680.42KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%